Norepinephrine Inhibition of Mesenchymal Stem Cell and Chondrogenic Progenitor Cell Chondrogenesis and Acceleration of Chondrogenic Hypertrophy
Open Access
- 12 May 2014
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatology
- Vol. 66 (9) , 2472-2481
Abstract
Objective: Mesenchymal progenitor cell chondrogenesis is the biologic platform for the generation or regeneration of cartilage, but the external influence of the sympathetic nervous system on this process is not yet known. Sympathetic nerve fibers are present in articular tissue, and the sympathetic nervous system influences the musculoskeletal system by, for example, increasing osteoclastogenesis. This study was initiated to explore the role of the sympathetic neurotransmitter norepinephrine (NE) in mesenchymal stem cell (MSC)–dependent and cartilage progenitor cell (CPC)–dependent chondrogenesis.Methods: Using human MSCs or CPCs, chondrogenic differentiation was induced in the presence of NE, the specific β‐adrenergic receptor (β‐AR) agonist isoproterenol, and the specific β‐AR antagonist nadolol. We studied sympathetic nerve fibers, tyrosine hydroxylase (TH) expression, catecholamine biosynthesis, and synovial fluid levels in human joints, as well as cartilage‐specific matrix deposition during differentiation.Results: TH+ sympathetic nerve fibers were present in the synovial tissue, meniscus, and subchondral bone marrow. In addition, synovial fluid from patients with knee trauma demonstrated high concentrations of NE. During MSC or CPC chondrogenesis, β‐AR were expressed. Chondrogenic aggregates treated with NE or isoproterenol synthesized lower amounts of type II collagen and glycosaminoglycans. NE and isoproterenol treatment dose‐dependently increased the levels of cartilage hypertrophy markers (type X collagen and matrix metalloproteinase 13). Nadolol reversed the inhibition of chondrogenesis and the up‐regulation of cartilage hypertrophy.Conclusion: Our findings demonstrate NE‐dependent inhibition of chondrogenesis and acceleration of hypertrophic differentiation. By inhibiting cartilage repair, these sympathetic influences can be important after joint trauma. These findings may be a basis for novel neurochondrogenic therapeutic options.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (AN 309/1-1 and CA 933/1-1)
This publication has 45 references indexed in Scilit:
- Chondrogenesis, chondrocyte differentiation, and articular cartilage metabolism in health and osteoarthritisTherapeutic Advances in Musculoskeletal Disease, 2012
- Osteoarthritis: A disease of the joint as an organArthritis & Rheumatism, 2012
- Relative percentage and zonal distribution of mesenchymal progenitor cells in human osteoarthritic and normal cartilageArthritis Research & Therapy, 2011
- Identification and Clonal Characterisation of a Progenitor Cell Sub-Population in Normal Human Articular CartilagePLOS ONE, 2010
- Teaching old receptors new tricks: biasing seven-transmembrane receptorsNature Reviews Drug Discovery, 2010
- Mesenchymal progenitor cell markers in human articular cartilage: normal distribution and changes in osteoarthritisArthritis Research & Therapy, 2009
- Expression of MicroRNA‐146a in osteoarthritis cartilageArthritis & Rheumatism, 2009
- Successful immortalization of mesenchymal progenitor cells derived from human placenta and the differentiation abilities of immortalized cellsBiochemical and Biophysical Research Communications, 2006
- Seven-transmembrane receptorsNature Reviews Molecular Cell Biology, 2002
- Protein Kinase A Regulates Chondrogenesis of Mesenchymal Cells at the Post-Precartilage Condensation Stage via Protein Kinase C-α SignalingJournal of Bone and Mineral Research, 2000